Founded in 1997, Ergomed is dedicated to the provision of specialist services to the global pharmaceutical industry. Today, Ergomed supports pharmaceutical companies with services spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Our business includes a full range of high-quality clinical research and clinical trial management services and internationally recognized expertise in orphan drug development together with an industry-leading suite of specialist pharmacovigilance solutions. By providing this full-service offering, Ergomed enables emerging and established life sciences companies to meet their regulatory obligations, maximize their drug development success and therefore their product value.